Keyphrases
Age Distribution
25%
Allogeneic Bone Marrow Transplantation
100%
Chemotherapy
25%
Complete Remission
25%
Cyclophosphamide
25%
Dose Rate
50%
Engraftment Rate
25%
First Remission
100%
Fractionated Whole Body gamma Irradiation (FWBGI)
25%
Graft-versus-host Disease (GvHD)
25%
Human Leukocyte Antigen
25%
Hyperfractionated
25%
Interstitial Pneumonitis
25%
Kaplan-Meier
25%
Lymphoblastic Leukemia
100%
Mixed Lymphocyte Culture
25%
Multivariate Analysis
25%
Nausea
25%
Newly Diagnosed
25%
Old Age
25%
Patient Characteristics
25%
Relapse Rate
50%
Relapse-free Survival
75%
Sibling Donor
25%
T Cell Depletion
25%
Total Body Irradiation
100%
Twice a Day
25%
Unrelated Donor
25%
Viral
25%
Vomiting
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Age Distribution
50%
Chemotherapy
50%
Cyclophosphamide
50%
Graft Versus Host Reaction
50%
Interstitial Pneumonia
50%
Leukocyte Antigen
50%
Nausea and Vomiting
50%
Recurrence Free Survival
100%
Recurrence Risk
100%
Remission
100%
Survival Rate
50%
Nursing and Health Professions
Acute Myeloid Leukemia
100%
Age Distribution
20%
Allogenic Bone Marrow Transplantation
100%
Cyclophosphamide
20%
Engraftment
20%
Graft Versus Host Reaction
20%
Interstitial Pneumonia
20%
Leukocyte Antigen
20%
Mixed Lymphocyte Culture
20%
Multivariate Analysis
20%
Nausea and Vomiting
20%
Recurrence Free Survival
40%
Recurrence Risk
40%
Remission
100%
Survival Rate
20%
Vascular Guide Wire
20%
Whole Body Radiation
100%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Age Distribution
20%
Allogenic Bone Marrow Transplantation
100%
Chemotherapy
20%
Cyclophosphamide
20%
Engraftment
20%
Graft Versus Host Reaction
20%
Human Leukocyte Antigen
20%
Idiopathic Interstitial Pneumonia
20%
Mixed Lymphocyte Culture
20%
Multivariate Analysis
20%
Nausea and Vomiting
20%
Patient Characteristics
20%
Recurrence Free Survival
40%
Recurrence Risk
40%
Survival Rate
20%
T Cell
20%
Whole Body Radiation
100%
Immunology and Microbiology
Age Distribution
50%
Allogeneic Bone Marrow Transplantation
100%
Cyclophosphamide
50%
Engraftment
50%
Graft-Versus-Host Disease
50%
Human Leukocyte Antigen
50%
Mixed Lymphocyte Culture
50%
Pneumonitis
50%
Recurrence Free Survival
100%
T Cell
50%